---  
layout: startup_page  
title: "Capstan Therapeutics"  
id: "capstantx.com"  
permalink: "/capstantherapeuticscapstantx.com03202024/"  
website: "https://www.capstantx.com"  
funding_round: "Series B"  
funding_amount: "$175M"  
investors: "RA Capital Management, Forbion, Johnson & Johnson Innovation - JJDC, Mubadala Capital, Perceptive Advisors, Sofinnova Investments, Alexandria Venture Investments, Bristol Myers Squibb, Eli Lilly and Company, Leaps by Bayer, Novartis Venture Fund, OrbiMed, Pfizer Ventures, Polaris Partners, Vida Ventures"  
about: "Capstan Therapeutics is a biotechnology company focused on advancing in vivo cell reprogramming through RNA delivery using targeted lipid nanoparticles (tLNP). Its core platform technology aims to create transformative therapies for various diseases by delivering payloads to reprogram specific cell types within the body. This approach offers potential applications across autoimmune disorders, oncology, fibrosis, and monogenic blood disorders."  
markets: "Biotechnology, RNA Therapeutics, Immunology, Oncology, Autoimmune Disorders"  
hq: "San Diego, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/capstan-therapeutics/"  
twitter: "https://twitter.com/capstantx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/capstan-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/495497-62"  

date_display: "20-Mar-2024"  
date: "2024-03-20"

# SEO Optimization  
meta_title: "Capstan Therapeutics - Series B Funding ($175M)"  
meta_description: "Capstan Therapeutics, Capstan Therapeutics is a biotechnology company focused on advancing in vivo cell reprogramming through RNA delivery using targeted lipid nanoparticle..."  
meta_keywords: "Capstan Therapeutics, Biotechnology, RNA Therapeutics, Immunology, Oncology, Autoimmune Disorders, Series B funding"  
canonical_url: "https://startup.projectstartups.com/capstantherapeuticscapstantx.com03202024/"  
---